These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 20008652)
1. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Lippa CF; Rosso AL; Stutzbach LD; Neumann M; Lee VM; Trojanowski JQ Arch Neurol; 2009 Dec; 66(12):1483-8. PubMed ID: 20008652 [TBL] [Abstract][Full Text] [Related]
2. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532 [TBL] [Abstract][Full Text] [Related]
3. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539 [TBL] [Abstract][Full Text] [Related]
4. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Mackenzie IR; Rademakers R Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115 [TBL] [Abstract][Full Text] [Related]
13. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117 [TBL] [Abstract][Full Text] [Related]
14. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094 [TBL] [Abstract][Full Text] [Related]
15. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease. Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226 [TBL] [Abstract][Full Text] [Related]
16. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774 [TBL] [Abstract][Full Text] [Related]
17. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Hu WT; Josephs KA; Knopman DS; Boeve BF; Dickson DW; Petersen RC; Parisi JE Acta Neuropathol; 2008 Aug; 116(2):215-20. PubMed ID: 18592255 [TBL] [Abstract][Full Text] [Related]